L E Marengere1, Z Songyang, G D Gish
1Division of Molecular and Developmental Biology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Researchers modified a key residue in the Src tyrosine kinase SH2 domain, switching its binding specificity. This engineered SH2 domain successfully activated the Ras pathway in vivo, demonstrating a link between SH2 binding specificity and biological function.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: